It is noteworthy that in differentiated human neuroblastoma cells VPA and other HDAC inhibitors were recently found to induce the downregulation of TrkB [57], whose expression in neuroblastoma is known to promote aggressiveness, chemotherapy resistance and metastasis [64]. Here, NTRK2 is linked to neuroblastoma.